Is Saal 13 Feesadi Rahegi Pharma Sector Ki Growth
Business » Wednesday, April 24, 2013
soma das nai Delhi Indian drag market ki growth is saal 11 se 13 feesadi rah sakti hai. Pharma market research farm aaiemaes helth aur peeteeee ne yah anumaan jataaya hai. Indian drag market 72,000 karod rupae ka hai. Do pratidvandvi market research farmon ke is optimistik aur ek jaise forakaast se pharma industry ko khush hone ka mauka milega. Pichhle 5 kvaartars mein pharma industry ki growth mein kami dekhne ko mili hai. Positive growth ke liye pichhle kuchh kvaartars mein pharma industry ki growth ke treind mein badlaav jaroori hoga. March 2012 quarter mein industry ki growth double dijit mein thi, jo March 2013 mein ghatkar singal dijit mein aa gayi. Agar kareeb 13 feesadi growth rate ka anumaan sahi saabit hota hai to is saal ki growth pichhle dashak mein haasil evarej enual growth jaisi rahegi. Peeteeee ki report ke mutaabik, growth rate March 2012 quarter ke 17 feesadi se ghatkar March 2013 quarter mein 7 feesadi par aa gayi hai. Udhar, aaiemaes helth ki report ke mutaabik bhi is avadhi mein growth 14.8 feesadi se 8.3 feesadi par aa gayi hai. Research farmon ne growth mein slodaaun ki vajah haai base ifekt, saamaanya se kamjor monsoon aur ovaraol ikanaumik slodaaun ko bataaya hai. Peeteeee ke director ameesh maasurekar ne kaha, 'Sirf December 2012 aur March 2013 mein khatm kvaartars mein growth rate 13 feesadi se neeche chali gayi. Agar aap December 2011 aur March 2012 kvaartars ke growth rate ki tulana karein, to ye 17 feesadi aur 18.5 feesadi rahe. Ye asal mein ye 13 feesadi ke laung tarm evarej growth rate ke mukaabale kaafi jyaada hain. Isliye aapne pichhle do kvaartars mein jo dekha hai, vah market karekshan hai. Aaiemaes helth ne loar growth rate ke liye kamjor monsoon aur ikanaumik slodaaun ko bhi jimmedaar bataaya. Research farm ke jeeem-saaooth Asia amit bakaleevaal ne kaha, 'Saamaanya se kamjor monsoon ke season impaikt ke alaava ikanaumi mein general slodaaun ne bhi 2012 mein pharma sector ke growth rate ko neeche la diya hai. 2013 mein India ke kareeb 6.2 feesadi ke GDP growth ke anumaan ko dekhte hue hamein poora bharosa hai ki aane vaale kvaartars mein pharma sector mein dheere-dheere sudhaar dikhaai dega. ' lyoopin jaisi kuchh dava companiyaan research farmon se jyaada utsaahit hain. Evarej 16 feesadi ki growth ke saath lyoopin Indian market mein sabse teji se badhne waali dava companiyon mein se ek hai. Iska kehna hai ki lo growth ka phase thode samay ke liye hai.